Table 1.

Effects of ATP, UTP, and LPS on release of 4 chemokines from dendritic cells

TreatmentIP-10 (ng/mL)RANTES (ng/mL)MDC (ng/mL)TARC (ng/mL)
None ND ND 65.2 ± 4.9 122 ± 16.2 
ATP ND ND 165 ± 15.2* 172 ± 28.3 
UTP ND ND 72.1 ± 9.0 134 ± 12.7 
LPS 11.3 ± 1.2 18.1 ± 1.7 315 ± 32.4 283 ± 27.1 
LPS + ATP ND 4.3 ± 0.6 512 ± 37.2 316 ± 29.6 
LPS + UTP 10.8 ± 0.8 17.5 ± 1.9 307 ± 35.4 266 ± 21.9 
TreatmentIP-10 (ng/mL)RANTES (ng/mL)MDC (ng/mL)TARC (ng/mL)
None ND ND 65.2 ± 4.9 122 ± 16.2 
ATP ND ND 165 ± 15.2* 172 ± 28.3 
UTP ND ND 72.1 ± 9.0 134 ± 12.7 
LPS 11.3 ± 1.2 18.1 ± 1.7 315 ± 32.4 283 ± 27.1 
LPS + ATP ND 4.3 ± 0.6 512 ± 37.2 316 ± 29.6 
LPS + UTP 10.8 ± 0.8 17.5 ± 1.9 307 ± 35.4 266 ± 21.9 

Dendritic cells were left untreated or stimulated with either 250 μM ATP, 250 μM UTP, 10 μg/mL LPS, LPS and ATP, or LPS and UTP. After 24 hours, chemokine levels in the supernatants were measured by enzyme-linked immunosorbent assay. Results are mean ± SD nanograms per milliliter/106 cells from 5 independent experiments.

ATP indicates adenosine triphosphate; UTP, uridine triphosphate; LPS, lipopolysaccharide; IP-10, interferon-inducible protein 10; RANTES, regulated upon activation, normal T-cell expressed and secreted; MDC, macrophage-derived chemokine; TARC, thymus- and activation-regulated chemokine; and ND, not detectable.

*

P < .03 compared with results with untreated or UTP-treated DCs.

P < .03 compared with results with DCs treated with LPS alone or with LPS and UTP.

Close Modal

or Create an Account

Close Modal
Close Modal